Effect of sulpiride, an atypical neuroleptic, on apomorphine-induced growth hormone secretion.
Sulpiride (100 mg IM), an atypical neuroleptic, which does not block dopamine (DA) receptors that are linked to adenylate cyclase, abolished the growth hormone (GH) response to the DA receptor agonist, apomorphine (Apo) HCl (0.5 mg SC) in seven healthy male subjects. These results suggest that Apo increases GH secretion in man by an effect on DA receptors that are not linked to adenylate cyclase.
D000328:Adult; D001058:Apomorphine; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D008297:Male; D010919:Placebos; D011388:Prolactin / Q000097:blood; D013469:Sulpiride
D010919:Placebos; D013469:Sulpiride; D011388:Prolactin; D013006:Growth Hormone; D001058:Apomorphine